Federal Supply Schedule 36F79718D0406
Award Date
4/15/18
Last Date to Order
4/14/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Focus Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract, awarded to First Nation Group LLC, a veteran-owned and service-disabled veteran-owned small business, provides drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12). The $225,000.00 contract has a performance period from September 15, 2024, to September 14, 2029. The price list includes a variety of pharmaceutical products, such as Cyclobenzaprine HCL...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025. The purpose of the contract is to provide drugs,...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to WG Critical Care, LLC, a for-profit limited liability company. The contract is for "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" with a ceiling value of $16,124,000.00 and a period of performance from June 15, 2024 to June 14, 2029. The contract is a multiple award, meaning it was awarded to more than one vendor. It was not set...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
The Federal Supply Schedule (FSS) contract 36F79718D0514 was awarded by the Department of Veterans Affairs (VA) to Alkermes, Inc. for the provision of pharmaceutical and hematology-related products. This multiple-award contract falls under the GSA Schedule 61-IB for Pharmaceuticals and Drugs, with a period of performance extending to July 31, 2025 and a total ceiling value of $186,349,650.00. The contract aims to procure a wide range of pharmaceutical and hematology products to support the...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to H2-Pharma LLC, a for-profit limited liability company. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The contract is for 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. This indicates the contract is focused on...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract has an award date of September 29, 2024 and a ceiling value of $225,000.00, with a period of performance through September 28, 2029. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under FSS category 65 I B. The prime contractor is Leading Pharma...